Saturday, March 21, 2026
ISSN 2765-8767
  • Survey
  • Podcast
  • Write for Us
  • My Account
  • Log In
Daily Remedy
  • Home
  • Articles
  • Podcasts
    The Impact of COVID-19 on Patient Trust

    The Impact of COVID-19 on Patient Trust

    March 3, 2026
    Debunking Myths About GLP-1 Medications

    Debunking Myths About GLP-1 Medications

    February 16, 2026
    The Future of LLMs in Healthcare

    The Future of LLMs in Healthcare

    January 26, 2026
    The Future of Healthcare Consumerism

    The Future of Healthcare Consumerism

    January 22, 2026
    Your Body, Your Health Care: A Conversation with Dr. Jeffrey Singer

    Your Body, Your Health Care: A Conversation with Dr. Jeffrey Singer

    July 1, 2025

    The cost structure of hospitals nearly doubles

    July 1, 2025
  • Surveys

    Surveys

    Public Sentiment on the Future of Peptides and Hormone Therapies in U.S. Medicine

    Public Sentiment on the Future of Peptides and Hormone Therapies in U.S. Medicine

    March 17, 2026
    Perceptions of Viral Wellness Practices on Social Media: A Likert-Scale Survey for Informed Readers

    Perceptions of Viral Wellness Practices on Social Media: A Likert-Scale Survey for Informed Readers

    March 1, 2026

    Survey Results

    Can you tell when your provider does not trust you?

    Can you tell when your provider does not trust you?

    January 18, 2026
    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
  • Home
  • Articles
  • Podcasts
    The Impact of COVID-19 on Patient Trust

    The Impact of COVID-19 on Patient Trust

    March 3, 2026
    Debunking Myths About GLP-1 Medications

    Debunking Myths About GLP-1 Medications

    February 16, 2026
    The Future of LLMs in Healthcare

    The Future of LLMs in Healthcare

    January 26, 2026
    The Future of Healthcare Consumerism

    The Future of Healthcare Consumerism

    January 22, 2026
    Your Body, Your Health Care: A Conversation with Dr. Jeffrey Singer

    Your Body, Your Health Care: A Conversation with Dr. Jeffrey Singer

    July 1, 2025

    The cost structure of hospitals nearly doubles

    July 1, 2025
  • Surveys

    Surveys

    Public Sentiment on the Future of Peptides and Hormone Therapies in U.S. Medicine

    Public Sentiment on the Future of Peptides and Hormone Therapies in U.S. Medicine

    March 17, 2026
    Perceptions of Viral Wellness Practices on Social Media: A Likert-Scale Survey for Informed Readers

    Perceptions of Viral Wellness Practices on Social Media: A Likert-Scale Survey for Informed Readers

    March 1, 2026

    Survey Results

    Can you tell when your provider does not trust you?

    Can you tell when your provider does not trust you?

    January 18, 2026
    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
Daily Remedy
No Result
View All Result
Home Featured

How Clinically Significant is a Healthy Diet?

A new rating system could help you cut through the health guidelines.

Aleksandr Aravkin by Aleksandr Aravkin
October 29, 2022
in Featured
0
How Clinically Significant is a Healthy Diet?

The big idea

We developed a new method for assessing health risks that our research suggests should make it a lot easier for people to determine which health advice to follow – and which to ignore. The approach, recently published in the journal Nature Medicine, offers a straightforward way for both policymakers and the general public to assess the strength of evidence for a given health risk – like consuming red meat – and the corresponding outcome – ischemic heart disease – using a rating system of one to five stars.

The system we developed is based on several systematic reviews of studies regarding risk factors like smoking and health outcomes such as lung cancer. Well-established relationships between risks and outcomes score between three and five stars, whereas cases in which research evidence is lacking or contradictory garner one to two stars.

In our analysis, only eight of the 180 pairs that we analyzed received the top rating of five stars, indicating very strong evidence of association. The relationship between smoking and lung cancer, as well as the relationship between high systolic blood pressure – the higher of the two numbers in a blood pressure reading – and ischemic heart disease were among those eight five-star pairs.

This rating system enables consumers to easily identify how harmful or protective a behavior may be and how strong the evidence is for each risk-outcome pair. For instance, a consumer seeing a low star rating can use that knowledge to decide whether to shift a health habit or choice.

In addition, we created an online, publicly available visualization tool that displays 50 risk-outcome pairs that we discussed in five recently published papers in Nature Medicine.

While the visualization tool provides a nuanced understanding of risk across the range of blood pressures, the five-star rating signals that the overall evidence is very strong. As a result, this means that clear guidelines can be given on the importance of controlling blood pressure.

Why it matters

Clear messages and evidence-based guidance regarding healthy behaviors are crucial. Yet health guidance is often contradictory and difficult to understand.

Currently, most epidemiological analyses make strong assumptions about relationships between risks and health outcomes, and study results often disagree as to the strength of risk-outcome relationships. It can be confusing for experts and nonexperts alike to parse through conflicting studies of varying strength of results and determine if a lifestyle change is needed.

This is where our method comes in: The star-based rating system can offer decision-makers and consumers alike much-needed context before headline-grabbing health guidance is dispensed and adopted.

For example, the average risk of ischemic heart disease with a blood pressure of 165 mmHG – or millimeters of mercury, the basic unit used for measuring pressure – is 4.5 times the risk of the disease with blood pressure of 100 mmHG; but this is just a single estimate. The relative risk of ischemic heart disease increases by more than four times across the blood pressure range, and there is inherent uncertainty in the estimate based on available data. The rating of five stars incorporates all of this information, and in this case means that relative risk of ischemic heart disease across the entire range of exposures increases by at least 85%.

On the other hand, take the example of red meat consumption. Consuming 100 grams of red meat per day – as opposed to none – results in a very modest (12%) increase in risk for ischemic heart disease. That’s why it scores a rating of just two stars, consistent with only a weak association.

People should be well aware of their levels of exposure to risks classified with three to five stars, such as systolic blood pressure. By monitoring and keeping one’s blood pressure as low as possible, a person can substantially reduce the risk of developing ischemic heart disease.

What’s next

Our hope is that decision-makers will be able to use our star rating system to create informed policy recommendations that will have the greatest benefits for human health. We also hope the public can use the ratings and the visualization tool as a way to more clearly understand the current level of knowledge for different pairs of health risks and outcomes.

Aleksandr Aravkin, Associate Professor of Applied Mathematics, University of Washington; Christian Razo, Postdoctoral Fellow at the Institute for Health Metrics and Evaluation, University of Washington, and Jeffrey Stanaway, Assistant Professor of Global Health and Health Metrics Sciences, University of Washington

This article is republished from The Conversation under a Creative Commons license. Read the original article.

Source: The Conversation
ShareTweet
Aleksandr Aravkin

Aleksandr Aravkin

Mr. Aravkin is an Associate Professor in the Department of Applied Mathematics and Director of Mathematical Sciences at the Institute for Health Metrics and Evaluation (IHME) at the University of Washington. At IHME, my team leads development and applications of mathematical tools for global health applications, together with software implementations. We work closely with domain scientists to understand emerging challenge and to conduct large-scale analyses using new tools. In Applied Mathematics, I work on developing and analyzing new optimization algorithms, which are key tools for statistical and epidemiological models as well as for machine learning and data science.

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Videos

summary

This episode explores deceptive pricing strategies in the GLP-1 medication market, highlighting how healthcare consumerism influences patient decisions and how to recognize and protect against misleading practices.

 key  topics

Deceptive pricing strategies in healthcare
The role of brand perception and pricing manipulation
The concept of drip pricing and hidden costs
The rise of healthcare consumerism and patient agency
Strategies for patients to identify and avoid deceptive practices

Chapters

00:00 The Evolution of the GLP-1 Telemedicine Market
01:12 How Pricing Is Obscured and Perceived Discounts Are Created
02:11 TrumpRx: Coupon Aggregator or Discount Store?
03:12 Why Price Deception Thrives in Healthcare
04:12 The Membership Fee Illusion and Hidden Costs
05:10 Brand Recognition and Drip Pricing Strategies
06:17 The Impact of Brand and Anchor Pricing on Perceived Value
07:16 The Role of Price Drip Strategies in Healthcare Pricing
08:15 The Rise of Healthcare Consumerism and Patient Agency
09:14 How to Protect Yourself from Deceptive Pricing Practices
10:09 Conclusion: Empowering Patients in a Complex Pricing Landscape
Unmasking Deceptive Pricing in Healthcare: What Patients Need to Know
YouTube Video zZgo1nLZVrY
Subscribe

Policy Shift in Peptide Regulation

Clinical Reads

GLP-1 Drugs Have Moved Past Weight Loss. Medicine Has Not Fully Caught Up.

Glucagon-Like Peptide–Based Therapies and Longevity: Clinical Implications from Emerging Evidence

by Daily Remedy
March 1, 2026
0

Glucagon-like peptide–based therapies are increasingly used for weight management and glycemic control, but their potential impact on long-term survival remains uncertain. The clinical question addressed in this report is whether treatment with glucagon-like peptide receptor agonists is associated with reductions in all-cause mortality and age-related morbidity beyond their established metabolic effects. This question matters because these agents are now prescribed across broad patient populations, including individuals without diabetes, and long-term exposure may influence cardiovascular, oncologic, and neurodegenerative outcomes. Understanding whether...

Read more

Join Our Newsletter!

Twitter Updates

Tweets by TheDailyRemedy

Popular

  • The Grey Market of Weight Loss: How Compounded GLP-1 Medications Continue Despite FDA Crackdowns

    The Grey Market of Weight Loss: How Compounded GLP-1 Medications Continue Despite FDA Crackdowns

    0 shares
    Share 0 Tweet 0
  • A Call to Action for Pain Patients and Advocates

    1 shares
    Share 0 Tweet 0
  • Retatrutide and the Acceleration of Metabolic Medicine

    0 shares
    Share 0 Tweet 0
  • Healthcare’s Logistics Push

    0 shares
    Share 0 Tweet 0
  • Practicing Medicine Under Consumer Scrutiny

    0 shares
    Share 0 Tweet 0
  • 628 Followers

Daily Remedy

Daily Remedy offers the best in healthcare information and healthcare editorial content. We take pride in consistently delivering only the highest quality of insight and analysis to ensure our audience is well-informed about current healthcare topics - beyond the traditional headlines.

Daily Remedy website services, content, and products are for informational purposes only. We do not provide medical advice, diagnosis, or treatment. All rights reserved.

Important Links

  • Support Us
  • About Us
  • Contact us
  • Privacy Policy
  • Terms and Conditions

Join Our Newsletter!

  • Survey
  • Podcast
  • About Us
  • Contact us

© 2026 Daily Remedy

No Result
View All Result
  • Home
  • Articles
  • Podcasts
  • Surveys
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner

© 2026 Daily Remedy